96452-8
Hepatocellular carcinoma risk panel - Serum or Plasma
Active
34444-0 Acarboxyprothrombin [Mass/volume] in Serum or Plasma
Part Descriptions
LP31830-0 Acarboxyprothrombin
Indicator of Vitamin K deficiency. Intended for use as an aid in the risk assessment of patients with chronic liver disease for the progression to hepatocellular carcinoma in conjunction with other laboratory findings, imaging studies and clinical assessment.
Source: Regenstrief Institute
Fully-Specified Name
- Component
- Acarboxyprothrombin
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Short Name
- Acarboxyprothrombin SerPl-mCnc
- Display Name
- Acarboxyprothrombin [Mass/Vol]
- Consumer Name Alpha Get Info
- Acarboxyprothrombin, Blood
Basic Attributes
- Class
- COAG
- Type
- Laboratory
- First Released
- Version 2.10
- Last Updated
- Version 2.73
- Change Reason
- Release 2.67: DefinitionDescription: Represented term description as Reference Information and linked it to the LOINC Component Part for Acarboxyprothrombin.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 5794
Member of these Panels
LOINC | Long Common Name |
---|---|
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Acarboxiprotrombina: |
es-ES | Spanish (Spain) | Acarboxiprotrombina: Synonyms: Cuantitativo |
es-AR | Spanish (Argentina) | proteína inducida en ausencia de vitamina K: |
et-EE | Estonian (Estonia) | Akarboksüprotrombiin: Synonyms: Juhuslik Kvantitatiivne Plasma Seerum Seerum või plasma |
fr-BE | French (Belgium) | Décarboxyprothrombine: |
fr-FR | French (France) | Décarboxyprothrombine: |
fr-CA | French (Canada) | Décarboxyprothrombine: |
it-IT | Italian (Italy) | Acarbossiprotrombina: Synonyms: Concentrazione di Massa Plasma Punto nel tempo (episodio) Siero Siero o Plasma Studio di coagulazione |
ko-KR | Korean (Korea, Republic Of) | 비타민 K 결핍 단백 유도: |
nl-NL | Dutch (Netherlands) | acarboxyprothrombine: Synonyms: coagulatiemethode |
pt-BR | Portuguese (Brazil) | Acarboxiprotrombina: Synonyms: Protein induced in Vitamin K Acsence or antagonists; |
ru-RU | Russian (Russian Federation) | Акарбоксипротромбин: Synonyms: Количественный Массовая концентрация Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
tr-TR | Turkish (Turkey) | Akarboksiprotrombin: |
zh-CN | Chinese (China) | 维生素K缺乏时诱导产生的蛋白质: Synonyms: PIVKA; |
Example Units
Unit | Source |
---|---|
ng/mL | Example UCUM Units |
96450-2 Hepatotocellular carcinoma risk [Score] GALAD
Term Description
The GALAD score provides the probability of a patient having hepatocellular carcinoma (HCC). It is calculated based on gender, age, alpha-fetoprotein (AFP)-L3, AFP, and des-gamma-carboxy prothrombin [DCP], and higher GALAD model scores correlate with increased risk of HCC. The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
Source: Regenstrief LOINC
Part Descriptions
LP421438-5 GALAD
The GALAD model is a statistical model for estimating the likelihood of hepatocellular carcinoma (HCC) in patients with chronic liver disease. The GALAD score is calculated based on gender, age, and concentrations of AFL-L3, AFP, and des-gamma-carboxy prothrombin (DCP). The GALAD model has been demonstrated to have higher diagnostic accuracy for the detection of HCC compared to these individual markers alone or in combination, as well as reported to be superior to ultrasound for HCC detection PMID: 30464023.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Hepatocellular carcinoma risk
- Property
- Score
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- GALAD
Additional Names
- Short Name
- GALAD Score
- Display Name
- Hepatotocellular carcinoma risk [Score] GALAD
- Consumer Name Alpha Get Info
- Hepatocellular carcinoma risk
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.70
- Change Reason
- Release 2.70: COMPONENT: Corrected typo Hepatotocellular to Hepatocellular.;
- Order vs. Observation
- Observation
Formula (Readable)
Z = -10.08 + 0.09 x age + 1.67 x sex + 2.34 log(10) (AFP) + 0.04 x AFP - L3 + 1.33 x log(10) (DCP), where sex = 1 for males, 0 for females.
Member of these Panels
LOINC | Long Common Name |
---|---|
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG51398-2 | Hepatocellular carcinoma risk| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo de carcinoma hepatocelular: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Riesgo de carcinoma hepatotocelular: |
fr-FR | French (France) | Risque de cancer hépatocellulaire: |
it-IT | Italian (Italy) | Carcinoma epatocellulare, rischio: Synonyms: Chimica paziente Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 肝细胞癌: Synonyms: 分值; |
Example Units
Unit | Source |
---|---|
{score} | Example UCUM Units |
96451-0 Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma
Fully-Specified Name
- Component
- Alpha-1-Fetoprotein & Alpha-1-Fetoprotein.L3 panel
- Property
- -
- Time
- Pt
- System
- Ser/Plas
- Scale
- -
- Method
Additional Names
- Short Name
- AFP+AFP.L3 Pnl SerPl
- Display Name
- Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel
- Consumer Name Alpha Get Info
- Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel, Blood
Basic Attributes
- Class
- PANEL.CHEM
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Order
- Panel Type
- Panel
Member of these Panels
LOINC | Long Common Name |
---|---|
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Panel de alfafetoproteína y alfafetoprotíina-L3: |
es-MX | Spanish (Mexico) | Panel de alfa-1-fetoproteína y alfa-1-fetoproteína L3: |
fr-FR | French (France) | Alpha-1-foetoprotéine et alpha-1-foetoprotéine L3 panel: |
it-IT | Italian (Italy) | Alfa-1-Fetoproteina & Alfa-1-Fetoproteina L3, panel: Synonyms: Alfa-1-Fetoproteina L3 Chimica Panel Alfa-1-Fetoproteina e Alfa-1-Fetoproteina L3 Plasma Punto nel tempo (episodio) Set di prescrizione chimica Siero Siero o Plasma |
nl-NL | Dutch (Netherlands) | alfa-1-foetoproteïne & alfa-1-foetoproteïne.L3 panel: |
zh-CN | Chinese (China) | Alpha-1-胎儿球蛋白与 Alpha-1-胎儿球蛋白.L3 组套: Synonyms: Ⅰ A1 型 A1 胎儿球蛋白 L3; |
1834-1 Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
Part Descriptions
LP14331-0 Alpha-1-Fetoprotein
Alpha-1-fetoprotein (AFP) is a key variable in prenatal screening for the detection of trisomy 18, 21 and neural tube defect. It is also the primary tumor marker for nonseminomatous testicular cancers. Post-operative AFP levels that remain above normal imply residual tumor, and/or tumor recurrence. AFP can be high in up to 70% of patients with primary hepatocellular carcinoma. Elevated AFP levels have occasionally been found in association with gastrointestinal tract cancers.
Serum AFP is also elevated in ataxia telangiectasia, hereditary tyrosinemia, teratocarcinoma, and non-cancerous hepatic conditions, such as acute viral hepatitis, chronic active hepatitis and cirrhosis. Elevation of serum AFP in non-cancerous hepatic diseases is usually transient.
Source: Regenstrief Institute
Fully-Specified Name
- Component
- Alpha-1-Fetoprotein
- Property
- MCnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Short Name
- AFP SerPl-mCnc
- Display Name
- AFP [Mass/Vol]
- Consumer Name Alpha Get Info
- Alpha-fetoprotein, Blood
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 1.0
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 502
Member of these Panels
LOINC | Long Common Name |
---|---|
96451-0 | Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma |
48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
49085-4 | First and Second trimester integrated maternal screen panel |
54037-7 | HEDIS 2009 panel |
57820-3 | HEDIS 2010 panel |
60442-1 | HEDIS 2011 panel |
67767-4 | HEDIS 2012 panel |
72199-3 | HEDIS 2013 panel |
74234-6 | HEDIS 2014 Value Sets |
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG5597-2 | Alpha-1-Fetoprotein| |
LG42656-5 | Alpha-1-Fetoprotein| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Alpha-1-Fetoprotein: Synonyms: AFP |
de-AT | German (Austria) | Synonyms: Alpha-Fetoprotein |
el-GR | Greek (Greece) | α1-εμβρυϊκή πρωτεΐνη: |
es-ES | Spanish (Spain) | Alfa-1-Fetoproteina: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Alfa-1-fetoproteína: |
es-AR | Spanish (Argentina) | alfa-1-fetoproteína: |
et-EE | Estonian (Estonia) | Alfafetoproteiin: Synonyms: Juhuslik Kvantitatiivne Plasma Seerum Seerum või plasma |
fr-FR | French (France) | Alpha-1-foetoprotéine: |
fr-BE | French (Belgium) | Alpha-1-foetoprotéine: Synonyms: AFP |
fr-CA | French (Canada) | Alpha-1-foetoprotéine: |
it-IT | Italian (Italy) | Alfa-1-Fetoproteina: Synonyms: Chimica Concentrazione di Massa Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
ko-KR | Korean (Korea, Republic Of) | 알파-1-태아단백: |
nl-NL | Dutch (Netherlands) | alfa-1-foetoproteïne: |
pt-BR | Portuguese (Brazil) | Alfa-1-Fetoproteína: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Альфа-1-фетопротеин: Synonyms: Количественный Массовая концентрация Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
tr-TR | Turkish (Turkey) | Alfa-1-Fetoprotein: |
uk-UA | Ukrainian (Ukraine) | Альфа-1-Фетопротеїн: Synonyms: A1; |
zh-CN | Chinese (China) | Alpha-1-胎儿球蛋白: Synonyms: Ⅰ A1 型 A1 胎儿球蛋白; |
Example Units
Unit | Source |
---|---|
ng/mL | Example UCUM Units |
ug/L | eCHN |
42332-7 Alpha-1-Fetoprotein L3/Alpha-1-fetoprotein.total in Serum or Plasma
Part Descriptions
LP36040-1 Alpha-1-Fetoprotein.L3
In oncology, AFP-L3 is an isoform of Alpha-fetoprotein (AFP), a substance typically used in the triple test during pregnancy and for screening chronic liver disease patients for hepatocellular carcinoma (HCC). AFP can be fractionated by affinity electrophoresis into 3 glycoforms: L1, L2, and L3 based on the reactivity with the lectin Lens culinaris agglutinin (LCA). AFP-L3 binds strongly to LCA via an additional α 1-6 fucose residue attached at the reducing terminus of N-acetylglucosamine; this is in contrast to the L1 isoform. It is the L1 isoform which is typically associated with non-HCC inflammation of liver disease condition. The L3 isoform is specific to malignant tumors and its detected presence can serve to identify patients whom need increased monitoring for the development of HCC in high risk populations (i.e. chronic hepatitis B & C and/or liver cirrhosis). AFP-L3% is now being considered as a tumor marker for the North American demographic.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Fully-Specified Name
- Component
- Alpha-1-Fetoprotein.L3/Alpha-1-Fetoprotein.total
- Property
- MFr
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
Additional Names
- Short Name
- AFP L3 MFr SerPl
- Display Name
- AFP L3/Total AFP [Mass fraction]
- Consumer Name Alpha Get Info
- Alpha-fetoprotein L3/Total Alpha-1-fetoprotein, Blood
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.16
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 4468
Member of these Panels
LOINC | Long Common Name |
---|---|
96451-0 | Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma |
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Alfa-1-fetoproteina L3/Alfa-1-fetoproteina.total: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Alfa-1-Fetoproteína.L3 / Alfa-1-Fetoproteína.total: |
et-EE | Estonian (Estonia) | Alfa-1-fetoproteiin.L3/alfa-1-fetoproteiin.üld: Synonyms: Juhuslik Kvantitatiivne Plasma Seerum Seerum või plasma |
fr-FR | French (France) | Alpha-1-foetoprotéine L3/alpha-1-foetoprotéine totale: |
fr-BE | French (Belgium) | Alpha-1-foetoprotéine.L3/Alpha-1-foetoprotéine.totale: Synonyms: AFP |
fr-CA | French (Canada) | Alpha-1-foetoprotéine.L3/Alpha-1-foetoprotéine.totale: |
it-IT | Italian (Italy) | Alfa-1-Fetoproteina L3/Alfa-1-fetoproteina.totale: Synonyms: Alfa-1-Fetoproteina L3 Chimica Frazione di massa Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
ko-KR | Korean (Korea, Republic Of) | 알파-1-태아단백.L3/총알파-1-태아단백: |
nl-NL | Dutch (Netherlands) | alfa-1-foetoproteïne.L3/alfa-1-foetoproteïne.totaal: |
pt-BR | Portuguese (Brazil) | Alfa-1-Fetoproteína.L3/Alfa-1-Fetoproteína.total: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Альфа-1-Фетопротеин.L3/Альфа-1-фетопротеин.общий: Synonyms: Количественный Массовая доля Плазма Сыворотка Сыворотка или Плазма Точка во времени; |
tr-TR | Turkish (Turkey) | Alfa-1-Fetoprotein.L3/Alfa-1-fetoprotein.total: |
zh-CN | Chinese (China) | Alpha-1-胎儿球蛋白.L3/Alpha-1-胎儿球蛋白.总计: Synonyms: Ⅰ A1 型 A1 胎儿球蛋白 L3; |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
% | REGENSTRIEF |
69048-7 Immunologist review of results
Fully-Specified Name
- Component
- Immunologist review
- Property
- Imp
- Time
- Pt
- System
- XXX
- Scale
- Nar
- Method
Additional Names
- Short Name
- Immunologist review
- Display Name
- Immunologist review [Interp]
- Consumer Name Alpha Get Info
- Immunologist review of test result
Basic Attributes
- Class
- MISC
- Type
- Laboratory
- First Released
- Version 2.38
- Last Updated
- Version 2.75
- Change Reason
- Release 2.75: ORDER_OBS: submitter requested change;
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 4075
Member of these Panels
LOINC | Long Common Name |
---|---|
96451-0 | Alpha-1-Fetoprotein and Alpha-1-Fetoprotein.L3 panel - Serum or Plasma |
90414-4 | B-cell phenotyping panel - Blood |
103575-7 | Cat epithelium IgE panel - Serum or Plasma |
102085-8 | CNS Demyelinating Disease Panel - Serum or Plasma by Flow cytometry (FC) |
104134-2 | Dementia evaluation panel - Cerebral spinal fluid |
104595-4 | Dengue virus Ab.IgG and IgM and NS1 Ag panel - Serum or Plasma |
104673-9 | Diabetes mellitus type 1 autoimmune panel - Serum or Plasma |
103574-0 | Dog dander IgE panel - Serum or Plasma |
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
90416-9 | Lymphocyte subset and B-cell phenotyping panel - Blood |
101416-6 | Pediatric autoimmune central nervous system disorders evaluation panel - Cerebral spinal fluid |
101417-4 | Pediatric autoimmune central nervous system disorders evaluation panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: Komm.Auto.AK |
es-ES | Spanish (Spain) | Revisión del inmunólogo: |
es-MX | Spanish (Mexico) | Revisión de inmunólogo: |
fr-FR | French (France) | Validation des résultats d'immunologie: |
it-IT | Italian (Italy) | Immunologo, esame: Synonyms: Esame di immunologo Impressione/interpretazione di studio Miscellanea Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | beoordeling door immunoloog: |
ru-RU | Russian (Russian Federation) | Иммунолог рецензия: Synonyms: Впечатление/интерпретация исследования Описательный Точка во времени; |
tr-TR | Turkish (Turkey) | İmmünolog değerlendirmesi: |
zh-CN | Chinese (China) | 免疫学家审核: Synonyms: 不明的; |
74019-1 Probability of developing disease assessed [Likelihood]
Term Description
The estimated likelihood of a patient developing a disease. Probability may be based a number of factors, including family history (pedigree) analysis, genetic algorithm results, pre- or post-test results, and general population data for disease prevalence.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Probability of developing disease assessed
- Property
- Likelihood
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
Additional Names
- Short Name
- Probability of disease
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 2.46
- Last Updated
- Version 2.73
- Change Reason
- Updated Property from RelRto to Likelihood based on the term description and original submitted request for the Probability of Disease concept in the HL7 Virtual Medical Record (vMR) implementation guide.
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 16758
Member of these Panels
LOINC | Long Common Name |
---|---|
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
74028-2 | Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDS |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Probabilidad de desarrollar enfermedad evaluada: |
it-IT | Italian (Italy) | Probabilità di sviluppare malattia valutata: Synonyms: Anamnesi paziente Punto nel tempo (episodio) |
zh-CN | Chinese (China) | 已评估疾病发生概率: Synonyms: 医疗服务对象; |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
46098-0 Sex
Part Descriptions
LP101395-4 Sex
In LOINC, sex refers to the biological sex of an organism, which is most commonly determined based on anatomy and physiology or genetic (chromosome) analysis. Our definition is based on the World Health Organization's definition of sex and gender: sex (male, female) refers to biological and physiological characteristics, and gender (masculine, feminine) refers to socially constructed roles, behaviors, activities, and attributes. (http://www.who.int/gender/whatisgender/en)
Source: Regenstrief LOINC, WHO: gender
Fully-Specified Name
- Component
- Sex
- Property
- Type
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
Additional Names
- Short Name
- Sex
Basic Attributes
- Class
- ADMIN.PATIENT.DEMOG
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.73
- Change Reason
- Changed Component from 'Gender' to 'Sex' to align with the World Health Organization (WHO) definition of this concept.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 2086
HL7® Attributes
HL7® Field ID- PID-8
Example Answer List LL1-9
Answer | Code | Score | Answer ID |
---|---|---|---|
Male | 1 | LA2-8 | |
Female | 2 | LA3-6 |
Member of these Panels
LOINC | Long Common Name |
---|---|
89070-7 | ADAPTABLE patient reported item set [ADAPTABLE] |
95556-7 | Adrenal cancer risk assessment and urine steroid fractions panel |
72110-0 | Alcohol Use Disorder Identification Test [AUDIT] |
95405-7 | Assay related variables panel [PhenX] |
103991-6 | CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 4.2 during assessment period [CMS Assessment] |
52747-3 | Continuity Assessment Record and Evaluation (CARE) tool - Expired |
52745-7 | Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Discharge |
55168-9 | Data Elements for Emergency Department Systems (DEEDS) Release 1.1 |
52743-2 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Acute Care |
52748-1 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Home Health Admission |
52746-5 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Interim |
69412-5 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Long term care hospital (LTCH) - version 1.0 |
52744-0 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Admission |
83265-9 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.4 [CMS Assessment] |
87414-9 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment] |
88329-8 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 2.0 [CMS Assessment] |
85645-0 | Deprecated Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 [CMS Assessment] |
85671-6 | Deprecated Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00 [CMS Assessment] |
85662-5 | Deprecated Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00 [CMS Assessment] |
85668-2 | Deprecated Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00 [CMS Assessment] |
45963-6 | Deprecated MDS basic assessment tracking form - version 2.0 |
86870-3 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA (NO/SO) item set [CMS Assessment] |
86874-5 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed OMRA start of therapy (NS/SS) item set [CMS Assessment] |
86875-2 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home and Swing bed tracking (NT/ST) item set [CMS Assessment] |
86522-0 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
86872-9 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
86871-1 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
86873-7 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
86877-8 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
86856-2 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) and Nursing home quarterly (NQ) item set [CMS Assessment] |
86876-0 | Deprecated MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set [CMS Assessment] |
88279-5 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment] |
88280-3 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment] |
88281-1 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
88282-9 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
88283-7 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
88284-5 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
88285-2 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
88286-0 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
88287-8 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set [CMS Assessment] |
88292-8 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
88288-6 | Deprecated MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set [CMS Assessment] |
88951-9 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA (NO and SO) item set [CMS Assessment] |
88952-7 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed OMRA start of therapy (NS and SS) item set [CMS Assessment] |
88953-5 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
88954-3 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
88945-1 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
88946-9 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
88947-7 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
88948-5 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home part A PPS discharge (NPE) item set [CMS Assessment] |
88949-3 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set [CMS Assessment] |
88955-0 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
88950-1 | Deprecated MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set [CMS Assessment] |
54580-6 | Deprecated Minimum Data Set - version 3.0 |
46462-8 | Deprecated Outcome and assessment information set (OASIS) form - version B1 |
57039-0 | Deprecated Outcome and assessment information set (OASIS) form - version C |
57190-1 | Deprecated Outcome and assessment information set (OASIS) form - version C - Start of care |
85907-4 | Deprecated Outcome and assessment information set (OASIS) form - version C2 - Start of care [CMS Assessment] |
68359-9 | End Stage Renal Disease (ESRD) Death Notification - OMB CMS form 2746 |
67868-0 | End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728 |
70297-7 | ESRD patient information panel |
86636-8 | Family planning report - FPAR 2.0 set |
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
47245-6 | HIV treatment form Document |
89963-3 | Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 3.0 during assessment period [CMS Assessment] |
93128-7 | Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 4.0 during assessment period [CMS Assessment] |
85626-0 | Kidney failure 2-year and 5-year risk panel by KFRE |
100203-9 | Knee Society Score post-op panel [Knee Society Score] |
100159-3 | Knee Society Score pre-op panel [Knee Society Score] |
78699-6 | Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter |
78698-8 | Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore |
87509-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00 during assessment period [CMS Assessment] |
93222-8 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 during assessment period [CMS Assessment] |
103949-4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1 during assessment period [CMS Assessment] |
87506-2 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00 during assessment period [CMS Assessment] |
93219-4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 during assessment period [CMS Assessment] |
103948-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1 during assessment period [CMS Assessment] |
87507-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00 during assessment period [CMS Assessment] |
93221-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 during assessment period [CMS Assessment] |
103946-0 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1 during assessment period [CMS Assessment] |
87508-8 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00 during assessment period [CMS Assessment] |
93220-2 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 during assessment period [CMS Assessment] |
103947-8 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1 during assessment period [CMS Assessment] |
90480-5 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] |
90479-7 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home and Swing bed tracking (NT and ST) item set during assessment period [CMS Assessment] |
90473-0 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] |
90477-1 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] |
90478-9 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] |
90474-8 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] |
90475-5 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] |
90481-3 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Optional State Assessment (OSA) item set during assessment period [CMS Assessment] |
91552-0 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Swing bed discharge (SD) item set during assessment period [CMS Assessment] |
90476-3 | MDS v3.0 - RAI v1.17.1, 1.17.2 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
101111-3 | MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] |
101108-9 | MDS v3.0 - RAI v1.18.11 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
101105-5 | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] |
101107-1 | MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] |
101109-7 | MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] |
101110-5 | MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] |
101106-3 | MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] |
101113-9 | MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set during assessment period [CMS Assessment] |
101112-1 | MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
104608-5 | MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] |
105008-7 | MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set during assessment period [CMS Assessment] |
103564-1 | MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] |
104606-9 | MDS v3.0 - RAI v1.19.1 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] |
105201-8 | MDS v3.0 - RAI v1.19.1 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] |
104552-5 | MDS v3.0 - RAI v1.19.1 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] |
104554-1 | MDS v3.0 - RAI v1.19.1 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] |
104607-7 | MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set during assessment period [CMS Assessment] |
104609-3 | MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
82259-3 | Metabolic equivalent of task and Resting metabolic rate panel |
89724-9 | Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers] |
91393-9 | Opioid risk tool panel |
88373-6 | Outcome and assessment information set (OASIS) form - version D, D1 - Start of care during assessment period [CMS Assessment] |
99131-5 | Outcome and assessment information set (OASIS) form - version E - Start of Care during assessment period [CMS Assessment] |
69723-5 | Patient Health Questionnaire (PHQ) [Reported] |
93149-3 | PhenX - bone age protocol 220301 |
62787-7 | PhenX domain - Diabetes |
62863-6 | PhenX domain - Infectious diseases and immunity |
62755-4 | PhenX domain - Neurology |
62263-9 | PhenX domain - Nutrition and dietary supplements |
62812-3 | PhenX domain - Physical activity and physical fitness |
62611-9 | PhenX domain - Respiratory |
63009-5 | PhenX domain - Social environments |
63067-3 | PhenX domain - Speech and hearing |
82287-4 | Physical activity panel |
69919-9 | Race, ethnicity, sex, primary language, disability - Health and Human Services (HHS) panel [HHS.ACA Section 4302] |
55140-8 | Vaccine Adverse Event Reporting System (VAERS) panel |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Sexo: |
es-MX | Spanish (Mexico) | Sexo: |
et-EE | Estonian (Estonia) | Sugu: Synonyms: Juhuslik |
fr-BE | French (Belgium) | Sexe: |
fr-CA | French (Canada) | Sexe: |
it-IT | Italian (Italy) | Sesso: Synonyms: Amministrativo Dati demografici del paziente Paziente Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | geslacht: |
ru-RU | Russian (Russian Federation) | Пол: Synonyms: Номинальный; |
tr-TR | Turkish (Turkey) | Cinsiyet: Synonyms: Seks Tür |
zh-CN | Chinese (China) | 性别: Synonyms: 分类型应答; |
30525-0 Age
Fully-Specified Name
- Component
- Age
- Property
- Time
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
Additional Names
- Short Name
- Age
- Display Name
- Age
- Consumer Name Alpha Get Info
- Age
Basic Attributes
- Class
- MISC
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 1937
Member of these Panels
LOINC | Long Common Name |
---|---|
58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
95405-7 | Assay related variables panel [PhenX] |
93478-6 | Busulfan area under the curve panel - Plasma |
68991-9 | Epidemiologically important information for public health reporting panel |
49085-4 | First and Second trimester integrated maternal screen panel |
48798-3 | First trimester maternal screen panel - Serum or Plasma |
49086-2 | First trimester maternal screen with nuchal translucency panel |
88677-0 | German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set |
96452-8 | Hepatocellular carcinoma risk panel - Serum or Plasma |
89543-3 | Laboratory ask at order entry panel |
84429-0 | Level 3 emergency medical services patient care report - recommended CDA R1 and R2 set |
78699-6 | Liver fibrosis score panel - Serum or Plasma Calculated by FibroMeter |
78698-8 | Liver fibrosis score panel - Serum or Plasma Calculated by HepaScore |
49087-0 | Maternal screen clinical predictors panel |
82259-3 | Metabolic equivalent of task and Resting metabolic rate panel |
89724-9 | Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC) [CDC Emergency Operations Centers] |
87825-6 | National Trauma Data Standard - version 2018 set |
91393-9 | Opioid risk tool panel |
98133-2 | Osteoporosis Index of Risk panel |
98139-9 | Osteoporosis Risk Assessment Instrument |
98146-4 | Osteoporosis Self-Assessment Tool |
93149-3 | PhenX - bone age protocol 220301 |
93340-8 | PhenX - complete blood count protocol 220501 |
62863-6 | PhenX domain - Infectious diseases and immunity |
62755-4 | PhenX domain - Neurology |
62812-3 | PhenX domain - Physical activity and physical fitness |
62710-9 | PhenX domain - Psychiatric |
62611-9 | PhenX domain - Respiratory |
63009-5 | PhenX domain - Social environments |
82287-4 | Physical activity panel |
81959-9 | Public health laboratory ask at order entry panel |
89544-1 | Pulmonary Embolism Rule-out Criteria panel PERC |
89694-4 | Pulmonary Embolism Severity Index panel [PESI] |
89549-0 | Revised Geneva Score panel |
48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
60687-1 | Test of Infant Motor Performance Version 5.1 |
55140-8 | Vaccine Adverse Event Reporting System (VAERS) panel |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Alter: |
es-ES | Spanish (Spain) | Edad: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Edad: |
es-AR | Spanish (Argentina) | edad: |
et-EE | Estonian (Estonia) | Vanus: Synonyms: Juhuslik Kvantitatiivne |
fr-FR | French (France) | Âge: |
fr-BE | French (Belgium) | Âge: |
fr-CA | French (Canada) | Âge: |
it-IT | Italian (Italy) | Età: Synonyms: Miscellanea paziente Punto nel tempo (episodio) Tempo (e.g. secondi) |
nl-NL | Dutch (Netherlands) | leeftijd: |
pt-BR | Portuguese (Brazil) | Idade: Synonyms: Point in time; |
ru-RU | Russian (Russian Federation) | Возраст: Synonyms: Время (в т.ч. в секундах) Количественный Точка во времени; |
tr-TR | Turkish (Turkey) | Yaş: |
zh-CN | Chinese (China) | 年龄: Synonyms: 医疗服务对象; |
Example Units
Unit | Source |
---|---|
a | Example UCUM Units |